Biogen Idec ( BIIB) target raised at Jefferies. Shares of BIIB now seen reaching $176, Jefferies said. Positive topling Hemophilia data. Buy rating.

Dell ( DELL) target cut at UBS to $10, UBS said. Sentiment likely to trump value in the near term.

Devon Energy ( DVN) estimates cut at Guggenheim through 2013, Guggenheim said. Company is leveraged to lower NGL and Canadian crude prices. Buy rating and $59 price target.

Halliburton ( HAL) estimates, target reduced at UBS. Shares of HAL now seen reaching $49, according to UBS. Estimates also cut, given sluggish domestic activity. Buy rating.

Kansas City Southern ( KSU) numbers raised at Credit Suisse. Shares of KSU now seen reaching $100, according to Credit Suisse. Estimates also increased, as cross-border traffic should continue to drive growth. Outperform rating.

Lennar ( LEN) estimates, target increased at Credit Suisse. LEN estimates were raised through 2013, Credit Suisse said. Company is realizing higher margins and paying lower taxes. Outperform rating and new $35.50 price target.

Rowan Companies ( RDC) numbers lowered at Jefferies. Shares of RDC now seen reaching $40, Jefferies said. Estimates also lowered on September fleet status report. Hold rating.

>To submit a news tip, email:


Follow TheStreet on Twitter and become a fan on Facebook.
This article was written by a staff member of TheStreet.

If you liked this article you might like

Dow, S&P 500 Set New Records as Fed Moves to Unwind Balance Sheet

PayPal Has Billions in Cash and Is On the Prowl for Acquisitions

PayPal Hunting for a Big Deal?

Cramer: Dominoes Are in Play Today

Novice Trade: Apple